Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Konkret geht es um den Diabetes-Patienten mit kardiovaskulären Erkrankungen oder Risiken, die Herzinsuffizienz sowie die kardiovaskuläre Primär- und Sekundärprävention. Sind Sie hier schon auf dem neuesten Stand? Unsere Experten beleuchten, wo und warum das bisherige Procedere geändert werden soll und was in der Praxis sinnvoll ist. Holen Sie sich Ihr Update und 2 CME-Punkte beim MMW-Webinar am 24. April von 17.30 bis 19 Uhr. 
Erweiterte Suche
Anmelden
nach oben
Current Urology Reports
Erschienen in: Current Urology Reports 2/2013

01.04.2013 | Urothelial Cancer (A Sagalowsky, Section Editor)

Current Role of PET, CT, MR for Invasive Bladder Cancer

verfasst von: Nathan Lawrentschuk, Sze Ting Lee, Andrew M. Scott

Erschienen in: Current Urology Reports | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

Imaging for urothelial cancer, particularly that located in the bladder, has generally been based on computed tomography (CT). However in more recent times the role of positron emission tomography-CT (PET-CT) has emerged and increasingly magnetic resonance (MR) imaging has become utilised. This concise review will outline the role of these modalities when dealing with muscle-invasive bladder cancer (MIBC).
Literatur
1.
Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60:277–300.PubMedCrossRef
2.
3.
•• Lee ST, Lawrentschuk N, Scott AM. Pet in prostate and bladder tumors. Semin Nucl Med. 2012;42:231–46. A comprehensive analysis on the limitations of staging as it currently stands for muscle invasive bladder cancer including with contemporary imaging.PubMed
4.
Stenzl A, Cowan NC, De Santis M, Jakse G, Kuczyk MA, Merseburger AS. The updated eau guidelines on muscle-invasive and metastatic bladder cancer. Eur Urol. 2009;55:815–25.PubMedCrossRef
5.
National Comprehensive Cancer Network (NCCN). Nccn clinical practice guidelines in oncology (nccn guidelines®)-bladder cancer 2012 (Version 1, 2013).
6.
Bostrom PJ, van Rhijn BWG, Fleshner N, Finelli A, Jewett MA, Thoms J, et al. Staging and staging errors in bladder cancer. Eur Urol Suppl. 2010;9:2–9.CrossRef
7.
• Vargas HA, Akin O, Schoder H, Olgac S, Dalbagni G, Hricak H, et al. Prospective evaluation of mri, (11)c-acetate pet/ct and contrast-enhanced ct for staging of bladder cancer. Eur J Radiol. 2012;81:4131–7. One of the few prospective studies examining CT, PET-CT and MR in a prospective fashion to stage bladder cancer.PubMedCrossRef
8.
Purysko AS, Leao Filho HM, Herts BR. Radiologic imaging of patients with bladder cancer. Semin Oncol. 2012;39:543–58.PubMedCrossRef
9.
• Green DA, Durand M, Gumpeni N, Rink M, Cha EK, Karakiewicz PI, et al. Role of magnetic resonance imaging in bladder cancer: Current status and emerging techniques. BJU Int. 2012;110:1463–70. A comprehensive analysis of the benefits and pitfalls of MR in bladder cancer as a staging tool for bladder cancer with a call for more prospective studies.PubMedCrossRef
10.
Giannarini G, Petralia G, Thoeny HC. Potential and limitations of diffusion-weighted magnetic resonance imaging in kidney, prostate, and bladder cancer including pelvic lymph node staging: a critical analysis of the literature. Eur Urol. 2012;61:326–40.PubMedCrossRef
11.
Lu YY, Chen JH, Liang JA, Wang HY, Lin CC, Lin WY, Kao CH. Clinical value of fdg pet or pet/ct in urinary bladder cancer: a systemic review and meta-analysis. Eur J Radiol. 2011.
12.
Paik ML, Scolieri MJ, Brown SL, Spirnak JP, Resnick MI. Limitations of computerized tomography in staging invasive bladder cancer before radical cystectomy. J Urol. 2000;163:1693–6.PubMedCrossRef
13.
Anjos DA, Etchebehere EC, Ramos CD, Santos AO, Albertotti C, Camargo EE. 18f-fdg pet/ct delayed images after diuretic for restaging invasive bladder cancer. J Nucl Med. 2007;48:764–70.PubMedCrossRef
14.
Kosuda S, Kison PV, Greenough R, Grossman HB, Wahl RL. Preliminary assessment of fluorine-18 fluorodeoxyglucose positron emission tomography in patients with bladder cancer. Eur J Nucl Med. 1997;24:615–20.PubMed
15.
Schoder H, Ong SC, Reuter VE, Cai S, Burnazi E, Dalbagni G, et al. Initial results with (11)c-acetate positron emission tomography/computed tomography (pet/ct) in the staging of urinary bladder cancer. Mol Imaging Biol. 2012;14:245–51.PubMedCrossRef
16.
Drieskens O, Oyen R, Van Poppel H, Vankan Y, Flamen P, Mortelmans L. Fdg-pet for preoperative staging of bladder cancer. Eur J Nucl Med Mol Imaging. 2005;32:1412–7.PubMedCrossRef
17.
Harkirat S, Anand S, Jacob M. Forced diuresis and dual-phase f-fluorodeoxyglucose-pet/ct scan for restaging of urinary bladder cancers. Indian J Radiol Imaging. 2010;20:13–9.PubMedCrossRef
18.
Kibel AS, Dehdashti F, Katz MD, Klim AP, Grubb RL, Humphrey PA, et al. Prospective study of [18f]fluorodeoxyglucose positron emission tomography/computed tomography for staging of muscle-invasive bladder carcinoma. J Clin Oncol. 2009;27:4314–20.PubMedCrossRef
19.
Bachor R, Kotzerke J, Reske SN, Hautmann R. Lymph node staging of bladder neck carcinoma with positron emission tomography. Urologe A. 1999;38:46–50.PubMedCrossRef
20.
Apolo AB, Riches J, Schoder H, Akin O, Trout A, Milowsky MI, et al. Clinical value of fluorine-18 2-fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography in bladder cancer. J Clin Oncol. 2010;28:3973–8.PubMedCrossRef
21.
Jadvar H, Quan V, Henderson RW, Conti PS. [f-18]-fluorodeoxyglucose pet and pet-ct in diagnostic imaging evaluation of locally recurrent and metastatic bladder transitional cell carcinoma. Int J Clin Oncol. 2008;13:42–7.PubMedCrossRef
Metadaten
Titel
Current Role of PET, CT, MR for Invasive Bladder Cancer
verfasst von
Nathan Lawrentschuk
Sze Ting Lee
Andrew M. Scott
Publikationsdatum
01.04.2013
Verlag
Current Science Inc.
Erschienen in
Current Urology Reports / Ausgabe 2/2013
Print ISSN: 1527-2737
Elektronische ISSN: 1534-6285
DOI
https://doi.org/10.1007/s11934-013-0308-y

Weitere Artikel der Ausgabe 2/2013

Current Urology Reports 2/2013 Zur Ausgabe

Urothelial Cancer (A Sagalowsky, Section Editor)

The Role of Systemic Chemotherapy in Management of Upper Tract Urothelial Cancer

Minimally Invasive Surgery (V Bird, Section Editor)

Update on use of Enhanced Imaging to Optimize Lymphadenectomy in Patients Undergoing Minimally Invasive Surgery for Urothelial Cancer of the Bladder

Bladder and Urothelial Cancer (A Sagalowsky, Section Editor)

Adjuvant Methods to Improve Results of Local Bladder Irrigations by Chemotherapy for NMIBC

Urothelial Cancer (A Sagalowsky, Section Editor)

Value of Fluorescence Cystoscopy in High Risk Non-muscle Invasive Bladder Cancer

Urothelial Cancer (A Sagalowsky, Section Editor)

Conservative Nephron-Sparing Treatment of Upper-Tract Tumors

Minimally Invasive Surgery (V Bird, Section Editor)

Current Status of Robot Assisted Laparoscopic Radical Nephroureterectomy for Management of Upper Tract Urothelial Carcinoma

Neu im Fachgebiet Urologie

22.04.2024 | Prostatakarzinom | Nachrichten

Stufenschema weist Prostatakarzinom zuverlässig nach

20.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Varikozelen bei Jugendlichen: Das Für und Wider der Operation

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Ureterstriktur: Innovative OP-Technik bewährt sich
weitere anzeigen

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen